ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 231

$628K Total Retail Price of All Prescriptions

Rank: 16 out of 231

329 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 5,701 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
FUROSEMIDE 341 296 1 6
LEVOTHYROXINE SODIUM 276 260 2 3
LISINOPRIL 189 171 3 1
METFORMIN HCL 160 139 4 7
HYDROCODONE-ACETAMINOPHEN 157 153 S3 5 21
ATORVASTATIN CALCIUM 135 122 6 8
SIMVASTATIN 129 112 7 2
AZITHROMYCIN 120 86 8 32
METOPROLOL TARTRATE 107 101 9 12
LEVOFLOXACIN 107 91 9 64
ZOLPIDEM TARTRATE 107 93 9 14
ATENOLOL 102 94 12 11
AMLODIPINE BESYLATE 92 90 13 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 69 14 22
NEXIUM 84 62 15 31
OXYCODONE HCL 83 56 S2 16 23
METOPROLOL SUCCINATE 83 74 16 13
OMEPRAZOLE 74 65 18 5
DONEPEZIL HCL 72 61 19 26
ACTOS 68 50 20 140
NAMENDA 67 55 21 47
KLOR-CON M20 66 63 22 75
SERTRALINE HCL 65 39 23 18
GABAPENTIN 64 48 24 15
POTASSIUM CHLORIDE 61 54 25 33
CRESTOR 60 49 26 19
OLANZAPINE 59 47 27 65
CEPHALEXIN 58 54 28 100
MELOXICAM 56 38 29 88
DIOVAN HCT 56 53 29 84
CIPROFLOXACIN HCL 55 53 31 58
PREDNISONE 55 43 31 41
POLYETHYLENE GLYCOL 3350 53 39 33 36
DIOVAN 53 46 33 27
AMOX TR-POTASSIUM CLAVULANATE 52 40 35 81
HYDROCHLOROTHIAZIDE 52 45 35 9
RANITIDINE HCL 51 38 37 51
VERAPAMIL ER 50 38 38 144
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.